Lacosamide, another therapeutic failure in essential tremor: An open-label trial

Authors

  • Alexandre Gironell MD, PHD,

    Corresponding author
    1. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Movement Disorders Unit, Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Catalonia, Spain
    • Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Movement Disorders Unit, Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Catalonia, Spain
    Search for more papers by this author
  • Javier Pagonabarraga MD, PHD,

    1. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Movement Disorders Unit, Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Catalonia, Spain
    Search for more papers by this author
  • Berta Pascual-Sedano MD, PHD,

    1. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Movement Disorders Unit, Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Catalonia, Spain
    Search for more papers by this author
  • Jaime Kulisevsky MD, PHD

    1. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Movement Disorders Unit, Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Catalonia, Spain
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary